Clinical Trials 296 Views BioInvent ready for Phase I/IIa Malin Otmani May 22, 2018 BioInvent International has received authorization …
Clinical Trials 394 Views Lundbeck expands clinical pipeline and divests preclinical research programs Malin Otmani May 22, 2018 The company starts the clinical …
Clinical Trials 542 Views New results from Targovax’s ONCOS-102 trial Malin Otmani May 3, 2018 The company announces results from …
Clinical Trials 346 Views New results from AstraZeneca’s ARCTIC trial Malin Otmani April 25, 2018 AstraZeneca and MedImmune announce results …
Clinical Trials 393 Views Update on Nordic Nanovector trial Malin Otmani April 13, 2018 The company provides an update …
Clinical Trials 521 Views First patient enrolled in Vaccibody’s clinical trial Malin Otmani April 5, 2018 The company announces informed consent …
Clinical Trials 442 Views Update on AstraZeneca’s MYSTIC trial Malin Otmani March 12, 2018 AstraZeneca and MedImmune announce an …
Clinical Trials 560 Views WntResearch delays its Phase 2 study Malin Otmani February 13, 2018 WntResearch announces that, after reviewing …
Clinical Trials 531 Views Acesion Pharma initiates Phase I study Malin Otmani February 9, 2018 The company has received approval …
Clinical Trials 634 Views Eurocine Vaccine launches clinical study Malin Otmani February 8, 2018 The company initiates a phase …
Clinical Trials 1189 Views New results from Astra’s Pegasus trial Malin Otmani February 8, 2018 AstraZeneca announces results from a …
Clinical Trials 535 Views Follicum receives approval for clinical trial Malin Otmani February 7, 2018 The company has received approval …
Clinical Trials 614 Views Positive results from Bavarian Nordic Malin Otmani February 7, 2018 Bavarian Nordic announces positive results …
Clinical Trials 410 Views Targovax announces new clinical trial data Malin Otmani February 7, 2018 The company has completed the safety …
Clinical Trials 517 Views Novo Nordisk demonstrate positive results with Semaglutide Malin Otmani February 1, 2018 The results from the SUSTAIN …
